Skip to main content

digital therapeutics

pandemic
By Tammy Lovell | 09:08 am | April 01, 2020
The startup is working with national emergency services to remotely triage, support and manage infected people in isolation.
By Dave Muoio | 04:53 pm | March 26, 2020
Somryst, a prescription digital therapeutic combining cognitive behavioral therapy and personalized sleep restriction, is the first software product to put the FDA's early Precertification Program framework through its paces. 
By Dave Muoio | 03:58 pm | March 11, 2020
Livongo Health, Hinge Health, Hello Heart, Torchlight and Whil each underwent "rigorous clinical, data security and business evaluation" for inclusion in the program.
By Dave Muoio | 08:50 pm | February 24, 2020
The large, multi-site investigation described clear improvement in objective symptoms of pediatric attention deficit, but was a bit muddier when describing subjective measures and long-term efficacy.
By Dave Muoio | 03:00 pm | January 15, 2020
Topline data released today by the digital therapeutics company also suggest that its FDA approval-pending treatment continued to deliver benefits with continued use.
By Dave Muoio | 03:45 pm | January 14, 2020
The pharma company walks away with the full license for Proteus' mental health treatment adherence technology.
By Dave Muoio | 05:05 pm | January 07, 2020
New agreements with five different tech companies and research organizations aim to expand and flesh out the digital therapeutics maker's product pipeline.
By Leontina Postelnicu | 06:30 am | December 16, 2019
Sidekick was previously selected to take part in the German pharma and life sciences giant's G4A programme.
By Laura Lovett | 04:48 pm | December 12, 2019
The study, which was presented at the Meeting of the American College of Neuropsychopharmacology yesterday, found that patients using the technology improved their sustained attention compared to those in the control group. 
By HIMSS TV | 08:03 am | November 25, 2019
Happify Health's Chris Wasden discusses getting at the root cause rather than just treating symptoms by addressing chronic conditions from a behavior-change perspective.